Table 1.

Summary of applications

Study	Type of strategy under investigation	Was the aim to inform an early assessment (i.e., R&D) rather than reimbursement?	Type of parameter(s) elicited
Garthwaite et al. [14]	Treatment	No	Event probabilities, time to event, dependency
Leal et al. [10]	Diagnostic/screening	No	Event probabilities, relative effectiveness, diagnostic accuracy
Girling et al. [15]	Treatment	Yes	Event probabilities, time to event
Stevenson et al. [16]	Prevents transmission	No	Event probabilities, time to event, relative effectiveness
Meads et al. [12]	Diagnostic/screening	Yes	Event probabilities, diagnostic accuracy, minimum important clinical difference
McKenna et al. [19]	Treatment	No	Event probabilities
Haakma et al. [13]	Diagnostic/screening	Yes	Diagnostic accuracy
Stevenson et al. [17]	Treatment	No	Event probabilities, relative effectiveness
Speight et al. [25]	Diagnostic/screening	No	Event probabilities
Sperber et al. [22]	Treatment	No	Event probabilities, relative effectiveness
Brodtkorb [26]	Several exercises conducted but insufficient detail reported on each
Colbourn et al. [28]	Diagnostic/screening	No	Event probabilities, relative effectiveness
Soares et al. [9]	Treatment	No	Event probabilities, relative effectiveness
Bojke et al. [18]	Treatment	No	Relative effectiveness, dependency
Cao et al. [11]	Diagnostic/screening	Yes	Relative effectiveness
Fischer et al. [23]	Treatment	No	Counts, time to event
Poncet et al. [27]	Diagnostic/screening	No	Event probabilities
Grigore et al. [24]	Treatment	No	Event probabilities
Wilson et al. [20]	Treatment	No	Event probabilities, relative effectiveness
Meeyai et al. [21]	Vaccine	No	Event probabilities
Grimm et al. [35]	Diagnostic/screening	No	Diffusion†

R&D, research and development.

^†Rate of implementation in clinical practice over time.